# Canadian Pradaxa Acute Stroke Safety Study

> **NCT02415855** · — · COMPLETED · sponsor: **University of Alberta** · enrollment: 101 (actual)

## Conditions studied

- Ischemic Attack, Transient
- Stroke

## Interventions

- **DRUG:** Dabigatran

## Key facts

- **NCT ID:** NCT02415855
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-05-18
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2020-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02415855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02415855, "Canadian Pradaxa Acute Stroke Safety Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02415855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*